111, Inc. (YI)
USD 8.42
(0.48%)
USD 8.42
(0.48%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.08 Billion CNY | -11.08% |
| 2022 | 3.47 Billion CNY | 10.43% |
| 2021 | 3.14 Billion CNY | 3.94% |
| 2020 | 3.02 Billion CNY | 87.95% |
| 2019 | 1.61 Billion CNY | 4.13% |
| 2018 | 1.54 Billion CNY | 102.57% |
| 2017 | 763.38 Million CNY | -18.93% |
| 2016 | 941.6 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 2.78 Billion CNY | -4.63% |
| 2024 Q1 | 2.92 Billion CNY | -5.32% |
| 2023 Q3 | 3.36 Billion CNY | 10.19% |
| 2023 FY | 3.08 Billion CNY | -11.08% |
| 2023 Q1 | 3.23 Billion CNY | -6.76% |
| 2023 Q4 | 3.08 Billion CNY | -8.09% |
| 2023 Q2 | 3.05 Billion CNY | -5.82% |
| 2022 Q1 | 3.01 Billion CNY | -4.27% |
| 2022 Q4 | 3.47 Billion CNY | 13.71% |
| 2022 FY | 3.47 Billion CNY | 10.43% |
| 2022 Q2 | 3.1 Billion CNY | 3.07% |
| 2022 Q3 | 3.05 Billion CNY | -1.58% |
| 2021 Q4 | 3.14 Billion CNY | 0.46% |
| 2021 FY | 3.14 Billion CNY | 3.94% |
| 2021 Q3 | 3.13 Billion CNY | -5.11% |
| 2021 Q2 | 3.3 Billion CNY | 7.17% |
| 2021 Q1 | 3.07 Billion CNY | 1.75% |
| 2020 Q4 | 3.02 Billion CNY | 11.22% |
| 2020 Q2 | 1.88 Billion CNY | 14.36% |
| 2020 FY | 3.02 Billion CNY | 87.95% |
| 2020 Q1 | 1.64 Billion CNY | 2.39% |
| 2020 Q3 | 2.72 Billion CNY | 44.31% |
| 2019 Q3 | 1.67 Billion CNY | -3.74% |
| 2019 Q2 | 1.73 Billion CNY | 8.4% |
| 2019 Q1 | 1.6 Billion CNY | 3.74% |
| 2019 Q4 | 1.61 Billion CNY | -3.81% |
| 2019 FY | 1.61 Billion CNY | 4.13% |
| 2018 Q2 | 1.07 Billion CNY | 38.71% |
| 2018 FY | 1.54 Billion CNY | 102.57% |
| 2018 Q4 | 1.54 Billion CNY | -8.7% |
| 2018 Q1 | 773.3 Million CNY | 1.3% |
| 2018 Q3 | 1.69 Billion CNY | 57.91% |
| 2017 FY | 763.38 Million CNY | -18.93% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 Q4 | 763.38 Million CNY | 0.0% |
| 2016 FY | 941.6 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | 5.25 Million USD | -58632.771% |
| BIMI International Medical Inc. | 35.71 Million USD | -8549.251% |
| China Jo-Jo Drugstores, Inc. | 95.05 Million USD | -3149.664% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 311.75 Million USD | -890.854% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 312.16 Million USD | -889.555% |
| Leafly Holdings, Inc. | 21.83 Million USD | -14047.177% |
| Leafly Holdings, Inc. | 21.83 Million USD | -14047.177% |
| LifeMD, Inc. | 58.48 Million USD | -5182.145% |
| LifeMD, Inc. | 58.48 Million USD | -5182.145% |
| TRxADE HEALTH, Inc. | 12.53 Million USD | -24547.39% |
| PetMed Express, Inc. | 175.09 Million USD | -1664.226% |
| Walgreens Boots Alliance, Inc. | 81.03 Billion USD | 96.188% |